Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Undiagnosed Diseases 1Pulmonary Disease, Chronic Obstructive 1Medication Adherence 1

Interventions

pembrolizumab 1282Specimen Handling 927Carboplatin 836Magnetic Resonance Spectroscopy 834Cyclophosphamide 807Cisplatin 735Nivolumab 680Paclitaxel 635Radiotherapy 617Gemcitabine 580Biopsy 559Bevacizumab 485Dexamethasone 444fludarabine 410Docetaxel 385venetoclax 372Oxaliplatin 367Capecitabine 361Fluorouracil 357atezolizumab 350durvalumab 340Rituximab 335Drug Therapy 333Radiosurgery 321Doxorubicin 319Blood Specimen Collection 317Standard of Care 311Pemetrexed 307Ipilimumab 303Radiation 287

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pharmacists × 1 year × Clear all
NCT05444062 2025-08-11

QLC+

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase NA Active not recruiting
330 enrolled

Undiagnosed Diseases, Pulmonary Disease, Chronic Obstructive, Medication Adherence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡